Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Multiple Myeloma"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&lookfor=%22Myeloma%22&type=Subject&page=10
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&lookfor=%22Myeloma%22&type=Subject&page=10
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&lookfor=%22Myeloma%22&type=Subject&page=10
PubPharm (7.414)
91
Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial : Optimizing Prolonged Treatment In Myeloma Using MRD Assessment (OPTIMUM)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
92
Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies : Nivolumab for Relapsed or Refractory Disease Post Chimeric Antigen Receptor T-Cell Treatment in Patients With Hematologic Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
93
Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma : A Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
94
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant : A RANDOMIZED, 2-ARM, PHASE 3 STUDY OF ELRANATAMAB (PF-06863135) VERSUS LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
95
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) : A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing Mezigdomide (CC-92480/BMS-986348), Carfilzomib, and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM): SUCCESSOR-2
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
96
CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study : CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
97
A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China : AN OPEN-LABEL, PHASE 1 STUDY EVALUATING THE PHARMACOKINETICS, SAFETY AND ANTI-TUMOR ACTIVITY OF PF-07901801 (TTI-622) MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
98
Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma : Remote Monitoring With Health-Coaching for Lifestyle Changes in Older Patients With Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
99
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) : A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE (PVd) OR CARFILZOMIB, DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO RECEIVED PRIOR ANTI-CD38 DIRECTED THERAPY
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
100
Study of SYS6020 in BCMA-positive Multiple Myeloma : A Phase І Study of BCMA-targeted Chimeric Antigen Receptor T Cell (SYS6020) Injection in Relapsed or Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
5
6
7
8
9
10
11
12
13
14
15
Nächster »
[742]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Multiple Myeloma
Medienart
7.367
Aufsätze
6.089
E-Ressourcen
6.066
E-Artikel
1.301
Gedruckte Aufsätze
47
Bücher
24
Gedruckte Bücher
23
E-Books
1
Hochschulschriften
Alle anzeigen ...
weniger ...
Zeitschriftentitel
3.159
ClinicalTrials.gov
1.401
Reactions weekly
800
Inpharma weekly
269
Annals of hematology
175
PharmacoEconomics & outcomes news
88
International journal of hematology
63
Drugs
49
Inpharma
43
BMC cancer
36
Current treatment options in oncology
30
Current hematologic malignancy reports
27
Journal of cancer research and clinical oncology
26
Journal of medical case reports
22
Cancer chemotherapy and pharmacology
21
Digestive diseases and sciences
20
Journal for ImmunoTherapy of Cancer
19
PharmacoEconomics
18
Drugs & aging
17
European journal of nuclear medicine and molecu...
17
Journal of hematology & oncology
Alle anzeigen ...
weniger ...
Thema
Multiple Myeloma
3.159
610
2.704
Study Type: Interventional
2.644
Neoplasms, Plasma Cell
1.336
Myeloma
1.194
Recruitment Status: Completed
955
Phase: Phase 2
791
Medical Condition: Multiple Myeloma
720
Recruitment Status: Recruiting
705
Bortezomib
657
Phase: Phase 1
587
Thalidomide
495
Dexamethasone
466
Lymphoma
440
Recruitment Status: Active, not recruiting
418
Study Type: Observational
367
Recruitment Status: Terminated
325
Zoledronic Acid
324
Leukemia
311
Lenalidomide
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.165
2020-
2.497
2010-2019
1.538
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
7.390
Englisch
11
Chinesisch
9
Deutsch
3
Russisch
3
Spanisch
3
Ukrainisch
2
Persisch
2
Portugiesisch
1
Französisch
1
Polnisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...